Gyre Therapeutics (GYRE) Profit After Tax: 2009-2025
Historic Profit After Tax for Gyre Therapeutics (GYRE) over the last 16 years, with Sep 2025 value amounting to $5.9 million.
- Gyre Therapeutics' Profit After Tax rose 107.84% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 114.12%. This contributed to the annual value of $17.9 million for FY2024, which is 120.94% up from last year.
- Latest data reveals that Gyre Therapeutics reported Profit After Tax of $5.9 million as of Q3 2025, which was up 276.65% from $1.6 million recorded in Q2 2025.
- Gyre Therapeutics' 5-year Profit After Tax high stood at $51.6 million for Q2 2022, and its period low was -$101.0 million during Q4 2023.
- In the last 3 years, Gyre Therapeutics' Profit After Tax had a median value of $3.8 million in 2023 and averaged -$5.1 million.
- Its Profit After Tax has fluctuated over the past 5 years, first crashed by 453.61% in 2021, then spiked by 359.09% in 2022.
- Over the past 5 years, Gyre Therapeutics' Profit After Tax (Quarterly) stood at -$20.3 million in 2021, then plummeted by 37.23% to -$27.9 million in 2022, then crashed by 261.95% to -$101.0 million in 2023, then skyrocketed by 100.56% to $569,000 in 2024, then soared by 107.84% to $5.9 million in 2025.
- Its Profit After Tax stands at $5.9 million for Q3 2025, versus $1.6 million for Q2 2025 and $3.7 million for Q1 2025.